Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare

Clinical genomics is a system of multiple stakeholders and institutions. Yet, studies focusing on the comparative perspectives of these stakeholders are limited. This study engages four groups of professionals (clinical geneticists, genetic counselors, laboratory professionals, and researchers) work...

Full description

Bibliographic Details
Main Authors: Yuwan Malakar, Justine Lacey, Natalie A. Twine, Denis C. Bauer
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:New Genetics and Society
Subjects:
Online Access:http://dx.doi.org/10.1080/14636778.2023.2192472
_version_ 1797681235830505472
author Yuwan Malakar
Justine Lacey
Natalie A. Twine
Denis C. Bauer
author_facet Yuwan Malakar
Justine Lacey
Natalie A. Twine
Denis C. Bauer
author_sort Yuwan Malakar
collection DOAJ
description Clinical genomics is a system of multiple stakeholders and institutions. Yet, studies focusing on the comparative perspectives of these stakeholders are limited. This study engages four groups of professionals (clinical geneticists, genetic counselors, laboratory professionals, and researchers) working in clinical genomics to investigate their perceptions of the benefits and risks of using genomics in Australian healthcare. The study is underpinned by a risk governance approach. For data collection, qualitative semi-structured interviews were used. Our results show that all professionals unanimously identified that the benefit of clinical genomics lies in improving health outcomes for patients. However, the risks associated with delivering this benefit differed by professional category. We found that the further the profession was from the patient (e.g. researcher) the narrower the perceived risks were amongst the individuals interviewed. However, “privacy” as a perceived risk was ranked highly by all professions indicating a shared desire for responsible data governance practices.
first_indexed 2024-03-11T23:41:45Z
format Article
id doaj.art-73deca2e259f4f299b2611216275e2df
institution Directory Open Access Journal
issn 1463-6778
1469-9915
language English
last_indexed 2024-03-11T23:41:45Z
publishDate 2023-01-01
publisher Taylor & Francis Group
record_format Article
series New Genetics and Society
spelling doaj.art-73deca2e259f4f299b2611216275e2df2023-09-19T15:22:19ZengTaylor & Francis GroupNew Genetics and Society1463-67781469-99152023-01-0142110.1080/14636778.2023.21924722192472Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcareYuwan Malakar0Justine Lacey1Natalie A. Twine2Denis C. Bauer3Commonwealth Scientific and Industrial Research Organisation (CSIRO)Commonwealth Scientific and Industrial Research Organisation (CSIRO)Commonwealth Scientific and Industrial Research Organisation (CSIRO)Commonwealth Scientific and Industrial Research Organisation (CSIRO)Clinical genomics is a system of multiple stakeholders and institutions. Yet, studies focusing on the comparative perspectives of these stakeholders are limited. This study engages four groups of professionals (clinical geneticists, genetic counselors, laboratory professionals, and researchers) working in clinical genomics to investigate their perceptions of the benefits and risks of using genomics in Australian healthcare. The study is underpinned by a risk governance approach. For data collection, qualitative semi-structured interviews were used. Our results show that all professionals unanimously identified that the benefit of clinical genomics lies in improving health outcomes for patients. However, the risks associated with delivering this benefit differed by professional category. We found that the further the profession was from the patient (e.g. researcher) the narrower the perceived risks were amongst the individuals interviewed. However, “privacy” as a perceived risk was ranked highly by all professions indicating a shared desire for responsible data governance practices.http://dx.doi.org/10.1080/14636778.2023.2192472perceived risksperceived benefitsclinical genomicsrisk governanceaustralia
spellingShingle Yuwan Malakar
Justine Lacey
Natalie A. Twine
Denis C. Bauer
Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare
New Genetics and Society
perceived risks
perceived benefits
clinical genomics
risk governance
australia
title Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare
title_full Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare
title_fullStr Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare
title_full_unstemmed Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare
title_short Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare
title_sort applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in australian healthcare
topic perceived risks
perceived benefits
clinical genomics
risk governance
australia
url http://dx.doi.org/10.1080/14636778.2023.2192472
work_keys_str_mv AT yuwanmalakar applyingariskgovernanceapproachtoexaminehowprofessionalsperceivethebenefitsandrisksofclinicalgenomicsinaustralianhealthcare
AT justinelacey applyingariskgovernanceapproachtoexaminehowprofessionalsperceivethebenefitsandrisksofclinicalgenomicsinaustralianhealthcare
AT natalieatwine applyingariskgovernanceapproachtoexaminehowprofessionalsperceivethebenefitsandrisksofclinicalgenomicsinaustralianhealthcare
AT deniscbauer applyingariskgovernanceapproachtoexaminehowprofessionalsperceivethebenefitsandrisksofclinicalgenomicsinaustralianhealthcare